NexgenRx Inc.
NEGXF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $20,401 | $18,115 | $19,249 | $30,594 |
| - Cash | $1,706 | $1,877 | $17,156 | $20,345 |
| + Debt | $534 | $462 | $429 | $405 |
| Enterprise Value | $19,229 | $16,700 | $2,522 | $10,654 |
| Revenue | $16,475 | $13,846 | $12,463 | $11,876 |
| % Growth | 19% | 11.1% | 4.9% | – |
| Gross Profit | $13,122 | $10,820 | $8,495 | $8,488 |
| % Margin | 79.6% | 78.1% | 68.2% | 71.5% |
| EBITDA | $2,324 | $1,031 | $1,678 | $4,334 |
| % Margin | 14.1% | 7.4% | 13.5% | 36.5% |
| Net Income | $615 | -$332 | -$22 | $4,048 |
| % Margin | 3.7% | -2.4% | -0.2% | 34.1% |
| EPS Diluted | 0.005 | -0.005 | -0 | 0.054 |
| % Growth | 206.4% | -1,649% | -100.5% | – |
| Operating Cash Flow | $1,150 | $1,277 | $3,369 | $3,016 |
| Capital Expenditures | -$318 | -$248 | -$502 | -$1,380 |
| Free Cash Flow | $833 | $1,029 | $2,867 | $1,636 |